MEB resubmiting its FDA 510(k) application for MEBsleep. After the last trial in 2020, the FDA said it required clinical data. MEB is moving ahead with this and will have a pre-submission meeting on July 1, 2021. MEB thinks it can complete the trial in about 6-8 weeks. Milestones are still a long way off but it might be one to watch in July when updates from the meeting and details regarding the trial should be released.
I should have pointed out that this is a dog stock but it can move nicely when it chooses to.
- Forums
- ASX - Short Term Trading
- Short Term Trading Week Starting: 26 Apr
Short Term Trading Week Starting: 26 Apr, page-69
-
- There are more pages in this discussion • 42 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Featured News
The Watchlist
UNT
UNITH LTD
Idan Schmorak, CEO
Idan Schmorak
CEO
Previous Video
Next Video
SPONSORED BY The Market Online